Induction of regular cytolytic T cell synapses by bispecific single-chain antibody constructs on MHC class I-negative tumor cells

Molecular Immunology

Volumn 43, Issue 6, 2006, Pages 763-771

  Offner, Sonja ^a   Hofmeister, Robert ^a   Romaniuk, Andrea ^a   Kufer, Peter ^a,b   Baeuerle, Patrick A ^a  

^a MICROMET AG   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

Bispecific antibody; Cytolytic synapse; Cytotoxic T cell

Indexed keywords

COMPLEMENTARY DNA; EPITHELIAL CELL ADHESION MOLECULE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; CYTOLYSIS; HUMAN; HUMAN CELL; LASER MICROSCOPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH CARCINOMA; T LYMPHOCYTE; TUMOR CELL;

ANTIBODIES, BISPECIFIC; CELL COMMUNICATION; CELL LINE, TUMOR; COCULTURE TECHNIQUES; EPITOPES, T-LYMPHOCYTE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; LYMPHOCYTE ACTIVATION; MICROSCOPY, CONFOCAL; NEOPLASMS; T-LYMPHOCYTES, CYTOTOXIC; TUMOR ESCAPE;

EID: 28944434529     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2005.03.007     Document Type: Article

References (37)

1. P. Anton van der Merwe, S.J. Davis, A.S. Shaw, and M.L. Dustin Cytoskeletal polarization and redistribution of cell-surface molecules during T cell antigen recognition Semin. Immunol. 12 2000 5 21
2. A. Armstrong, and S.L. Eck EpCAM: A new therapeutic target for an old cancer antigen Cancer Biol. Ther. 2 2003 320 326
3. P.A. Baeuerle, P. Kufer, and R. Lutterbuse Bispecific antibodies for polyclonal T-cell engagement Curr. Opin. Mol. Ther. 5 2003 413 419
4. M. Balzar, M.J. Winter, C.J. de Boer, and S.V. Litvinov The biology of the 17-1A antigen (Ep-CAM) J. Mol. Med. 77 1999 699 712
5. S.M. Berney, T. Schaan, R.E. Wolf, H. van der Heyde, and T.P. Atkinson CD2 (OKT11) augments CD3-mediated intracellular signaling events in human T lymphocytes J. Investig. Med. 48 2000 102 109
6. B.A. Bladergroen, C.J. Meijer, R.L. ten Berge, C.E. Hack, J.J. Muris, D.F. Dukers, A. Chott, Y. Ka-zama, J.J. Oudejans, O. van Berkum, and J.A. Kummer Expression of the granzyme B inhibitor, protease inhibitor 9, by tumor cells in patients with non-Hodgkin and Hodgkin lymphoma: a novel protective mechanism for tumor cells to circumvent the immune system? Blood 99 2002 232 237
7. T. Boon, J.C. Cerottini, B. Van den Eynde, P. van der Bruggen, and A. Van Pel Tumor antigens recognized by T lymphocytes Annu. Rev. Immunol. 12 1994 337 365
8. J. Bubenik Tumour MHC class I downregulation and immunotherapy (Review) Oncol Rep 10 2003 2005 2008
9. H. Dong, S.E. Strome, D.R. Salomao, H. Tamura, F. Hirano, D.B. Flies, P.C. Roche, J. Lu, G. Zhu, K. Tamada, V.A. Lennon, E. Celis, and L. Chen Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion Nat. Med. 8 2002 793 800
10. T. Dreier, P.A. Baeuerle, I. Fichtner, M. Grun, B. Schlereth, G. Lorenczewski, P. Kufer, R. Lutterbuse, G. Riethmuller, P. Gjorstrup, and R.C. Bargou T cell costimulus-independent and very efficacious inhibition of tumor growth in mice bearing subcutaneous or leukemic human B cell lymphoma xenografts by a CD19-/CD3- bispecific single-chain antibody construct J. Immunol. 170 2003 4397 4402
11. T. Dreier, G. Lorenczewski, C. Brandl, P. Hoffmann, U. Syring, F. Hanakam, P. Kufer, G. Riethmuller, R. Bargou, and P.A. Baeuerle Extremely potent, rapid and costimulation-independent cytotoxic T-cell response against lymphoma cells catalyzed by a single-chain bispecific antibody Int. J. Cancer 100 2002 690 697
12. M.L. Dustin Coordination of T cell activation and migration through formation of the immunological synapse Ann. NY Acad. Sci. 987 2003 51 59
13. M. Faroudi, C. Utzny, M. Salio, V. Cerundolo, M. Guiraud, S. Muller, and S. Valitutti Lytic versus stimulatory synapse in cytotoxic T lymphocyte/target cell interaction: manifestation of a dual activation threshold Proc. Natl. Acad. Sci. U.S.A. 100 2003 14145 14150
14. L. Gorelik, and R.A. Flavell Immune-mediated eradication of tumors through the blockade of transforming growth factor-beta signaling in T cells Nat. Med. 7 2001 1118 1122
15. N.J. Hutchings, N. Clarkson, R. Chalkley, A.N. Barclay, and M.H. Brown Linking the T cell surface protein CD2 to the actin-capping protein CAPZ via CMS and CIN85 J. Biol. Chem. 278 2003 22396 22403
16. M. Knabel, T.J. Franz, M. Schiemann, A. Wulf, B. Villmow, B. Schmidt, H. Bernhard, H. Wagner, and D.H. Busch Reversible MHC multimer staining for functional isolation of T-cell populations and effective adoptive transfer Nat. Med. 8 2002 631 637
17. A. Kupfer, S.L. Swain, and S.J. Singer The specific direct interaction of helper T cells and antigen-presenting B cells II. Reorientation of the microtubule organizing center and reorganization of the membrane-associated cytoskeleton inside the bound helper T cells J. Exp. Med. 165 1987 1565 1580
18. H.O. Lee, and T.A. Ferguson Biology of FasL Cytokine Growth Factor Rev. 14 2003 325 335
19. K.H. Lee, A.R. Dinner, C. Tu, G. Campi, S. Raychaudhuri, R. Varma, T.N. Sims, W.R. Burack, H. Wu, J. Wang, O. Kanagawa, M. Markiewicz, P.M. Allen, M.L. Dustin, A.K. Chakraborty, and A.S. Shaw The immunological synapse balances T cell receptor signaling and degradation Science 302 2003 1218 1222
20. K.H. Lee, A.D. Holdorf, M.L. Dustin, A.C. Chan, P.M. Allen, and A.S. Shaw T cell receptor signaling precedes immunological synapse formation Science 295 2002 1539 1542
21. O. Leupin, R. Zaru, T. Laroche, S. Muller, and S. Valitutti Exclusion of CD45 from the T-cell receptor signaling area in antigen-stimulated T lymphocytes Curr. Biol. 10 2000 277 280
22. A. Loffler, M. Gruen, C. Wuchter, F. Schriever, P. Kufer, T. Dreier, F. Hanakam, P.A. Baeuerle, K. Bommert, L. Karawajew, B. Dorken, and R.C. Bargou Efficient elimination of chronic lymphocytic leukaemia B cells by autologous T cells with a bispecific anti-CD 19/anti-CD3 single-chain antibody construct Leukemia 17 2003 900 909
23. A. Loffler, P. Kufer, R. Lutterbuse, F. Zettl, P.T. Daniel, J.M. Schwenkenbecher, G. Riethmuller, B. Dorken, and R.C. Bargou A recombinant bispecific single-chain antibody, CD19 × CD3, induces rapid and high lymphoma-directed cytotoxicity by unstimulated T lymphocytes Blood 95 2000 2098 2103
24. M. Mack, R. Gruber, S. Schmidt, G. Riethmuller, and P. Kufer Biologic properties of a bispecific single-chain antibody directed against 17-1A (EpCAM) and CD3: tumor cell-dependent T cell stimulation and cytotoxic activity J. Immunol. 158 1997 3965 3970
25. M. Mack, G. Riethmuller, and P. Kufer A small bispecific antibody construct expressed as a functional single-chain molecule with high tumor cell cytotoxicity Proc Natl. Acad. Sci. USA 92 1995 7021 7025
26. R.T. Maziarz, S.J. Burakoff, and D.V. Faller The regulation of exogenous and endogenous class I MHC genes in a human tumor cell line, K562 Mol. Immunol. 27 1990 135 142
27. S.L. Moores, L.M. Selfors, J. Fredericks, T. Breit, K. Fujikawa, F.W. Alt, J.S. Brugge, and W. Swat Vav family proteins couple to diverse cell surface receptors Mol. Cell Biol. 20 2000 6364 6373
28. D. Nagorsen, C. Scheibenbogen, F.M. Marincola, A. Letsch, and U. Keilholz Natural T cell immunity against cancer Clin. Cancer Res. 9 2003 4296 4303
29. J.P. O'Keefe, K. Blaine, M.L. Alegre, and T.F. Gajewski Formation of a central supramolecu-lar activation cluster is not required for activation of naive CD8+ T cells Proc. Natl. Acad. Sci. U.S.A. 101 2004 9351 9356
30. D.M. Segal, G.J. Weiner, and L.M. Weiner Bispecific antibodies in cancer therapy Curr. Opin. Immunol. 11 1999 558 562
31. S. Shaw, G.E. Luce, R. Quinones, R.E. Gress, T.A. Springer, and M.E. Sanders Two antigen-independent adhesion pathways used by human cytotoxic T-cell clones Nature 323 1986 262 264
32. K. Somersalo, N. Anikeeva, T.N. Thomas, V.K. Strong, R.K. Spies, T. Lebedeva, T. Sykulev, and M.L. Dustin Cytotoxic T lymphocytes form an antigen-independent ring junction J. Clin. Invest. 113 2004 49 57
33. H. Spits, W. van Schooten, H. Keizer, G. van Seventer, M. van de Rijn, C. Terhorst, and J.E. de Vries Alloantigen recognition is preceded by nonspecific adhesion of cytotoxic T cells and target cells Science 232 1986 403 405
34. J.C. Stinchcombe, G. Bossi, S. Booth, and G.M. Griffiths The immunological synapse of CTL contains a secretory domain and membrane bridges Immunity 15 2001 751 761
35. A.T. Stopeck, A. Gessner, T.P. Miller, E.M. Hersh, C.S. Johnson, H. Cui, Y. Frutiger, and T.M. Grogan Loss of B7.2 (CD86) and intracellular adhesion molecule 1 (CD54) expression is associated with decreased tumor-infiltrating T lymphocytes in diffuse B-cell large-cell lym-phoma Clin. Cancer Res. 6 2000 3904 3909
36. M. Urosevic, M.O. Kurrer, J. Kamarashev, B. Mueller, W. Weder, G. Burg, R.A. Stahel, R. Dummer, and A. Trojan Human leukocyte antigen G up-regulation in lung cancer associates with high-grade histology, human leukocyte antigen class I loss and interleukin-10 production Am. J. Pathol. 159 2001 817 824
37. C. Uyttenhove, L. Pilotte, I. Theate, V. Stroobant, D. Colau, N. Parmentier, T. Boon, and B.J. Van Den Eynde Evidence for atumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase Nat. Med. 9 2003 1269 1274